INTERNATIONAL PATENT: SUNGKWANG MEDICAL FOUNDATION, 의료법인 성광의료재단, CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, 차의과학대학교 산학협력단 FILES APPLICATION FOR "IMMUNE CELL COMPRISING TUMOR-TARGETING CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF"

Posted On: 2026-04-29

GENEVA, April 29 -- SUNGKWANG MEDICAL FOUNDATION (566 Nonhyeon-ro,Gangnam-gu,Seoul 06135), 의료법인 성광의료재단 (서울특별시강남구논현로 566), CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (120 Haeryong-roPocheon-siGyeonggi-do 11160), 차의과학대학교 산학협력단 (경기도포천시해룡로 120) filed a patent application (PCT/KR2025/016504) for "IMMUNE CELL COMPRISING TUMOR-TARGETING CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF" on Oct 17, 2025. With publication no. WO/2026/084521, the details r...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: SUNGKWANG MEDICAL FOUNDATION, 의료법인 성광의료재단, CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, 차의과학대학교 산학협력단 FILES APPLICATION FOR "IMMUNE CELL COMPRISING TUMOR-TARGETING CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF"